Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 3/A Insider 3/A
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale Chief Legal Officer and EVP sold 5,471 shares at $5.75 ($31,478)
  9. 4 Open-market sale Shaff Eric D. sold 4,378 shares at $5.75 ($25,188)
  10. 4 Exercise or conversion Chief Technology Officer acquired 7,500 shares (option exercise)
  11. 4 Exercise or conversion COOK DAVID N acquired 7,500 shares (option exercise)
  12. 4 Open-market sale Chief Technology Officer & EVP sold 14,282 shares at $6.39 ($91,313)
  13. 4 Open-market sale Aunins John G. sold 14,279 shares at $8.26 ($117,912)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale Aunins John G. sold 14,279 shares at $5.94 ($84,800)
  17. 4 Open-market sale Aunins John G. sold 42,837 shares at an average $7.64 ($327,345)
  18. 4 Open-market sale President and CEO sold 1,810 shares at $9.00 ($16,291)
  19. 4 Open-market sale President and CEO sold 12,518 shares at an average $9.10 ($113,950)
  20. 4 Derivatives Options or other derivatives

Page 13 of 19 · 380 filings